1. Home
  2. SGMO vs TSE Comparison

SGMO vs TSE Comparison

Compare SGMO & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • TSE
  • Stock Information
  • Founded
  • SGMO 1995
  • TSE 2010
  • Country
  • SGMO United States
  • TSE United States
  • Employees
  • SGMO N/A
  • TSE N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • TSE Major Chemicals
  • Sector
  • SGMO Health Care
  • TSE Industrials
  • Exchange
  • SGMO Nasdaq
  • TSE Nasdaq
  • Market Cap
  • SGMO 180.5M
  • TSE 157.3M
  • IPO Year
  • SGMO 2000
  • TSE 2014
  • Fundamental
  • Price
  • SGMO $1.96
  • TSE $3.47
  • Analyst Decision
  • SGMO Buy
  • TSE
  • Analyst Count
  • SGMO 3
  • TSE 0
  • Target Price
  • SGMO $7.00
  • TSE N/A
  • AVG Volume (30 Days)
  • SGMO 11.1M
  • TSE 341.4K
  • Earning Date
  • SGMO 11-12-2024
  • TSE 11-06-2024
  • Dividend Yield
  • SGMO N/A
  • TSE 1.15%
  • EPS Growth
  • SGMO N/A
  • TSE N/A
  • EPS
  • SGMO N/A
  • TSE N/A
  • Revenue
  • SGMO $52,291,000.00
  • TSE $3,529,200,000.00
  • Revenue This Year
  • SGMO N/A
  • TSE N/A
  • Revenue Next Year
  • SGMO $71.79
  • TSE $4.87
  • P/E Ratio
  • SGMO N/A
  • TSE N/A
  • Revenue Growth
  • SGMO N/A
  • TSE N/A
  • 52 Week Low
  • SGMO $0.30
  • TSE $1.94
  • 52 Week High
  • SGMO $3.18
  • TSE $8.83
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 51.89
  • TSE 34.18
  • Support Level
  • SGMO $1.82
  • TSE $3.15
  • Resistance Level
  • SGMO $2.11
  • TSE $3.92
  • Average True Range (ATR)
  • SGMO 0.38
  • TSE 0.32
  • MACD
  • SGMO -0.10
  • TSE -0.05
  • Stochastic Oscillator
  • SGMO 16.44
  • TSE 20.25

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include latex binders, feedstocks, polystyrene, Americas styrenics, engineered materials, and plastics solutions. Majority of the revenue is generated from its Polystyrene segment which provides a variety of general purpose polystyrenes, and high impact polystyrene. These products provide customers with performance and aesthetics at a relatively low cost across applications, including appliances, packaging, including food packaging and food service disposables, consumer electronics and building and construction materials. Geographically, the company generates majority of the revenue from Europe and also has its presence in United States, Asia-Pacific and other regions.

Share on Social Networks: